Latest filing published 06 Jan 2022 for Horizon Therapeutics Public Ltd Co.
Filing timeline
BuySaleInsider track record
Barry Moze: trading record in brief
All filings by Barry Moze on record concern Horizon Therapeutics Public Ltd Co, in the capacity of senior executive. Over a trading history stretching from 19 May 2015 to 5 January 2022, the count stands at 73 filings.
No open-market purchase appears, only 19 sales worth €21.4M. Besides market trades, the filings include 30 share grants and 24 option exercises.
The latest filing, published on 6 January 2022, reports a share grant in Horizon Therapeutics Public Ltd Co. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Barry Moze
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 47,375 shares0Ordinary SharesSEC:0001209191-22-002287:1
- 49,841 shares@ US$101.8414.2% of flowOrdinary SharesSEC:0001209191-22-002287:2
- 64,959 sharesOrdinary SharesSEC:0001209191-22-002287:0
- 443 shares@ US$11.810.0% of flowOrdinary SharesSEC:0001209191-21-063200:1
- 72,300 shares@ US$14.483.3% of flowOrdinary SharesSEC:0001209191-21-063200:2
- 23,382 shares@ US$110.178.2% of flowOrdinary SharesSEC:0001209191-21-063200:3
- 15,856 shares@ US$111.755.6% of flowOrdinary SharesSEC:0001209191-21-063200:4
- 6,151 shares@ US$112.602.2% of flowOrdinary SharesSEC:0001209191-21-063200:5
- 17,867 shares@ US$113.566.4% of flowOrdinary SharesSEC:0001209191-21-063200:6
- 6,763 shares@ US$114.432.5% of flowOrdinary SharesSEC:0001209191-21-063200:7
- 5,724 shares@ US$115.452.1% of flowOrdinary SharesSEC:0001209191-21-063200:8
- 3,000 shares@ US$22.148.4% of flowOrdinary SharesSEC:0001209191-21-063200:0
- 3,215 shares@ US$102.501.0% of flowOrdinary SharesSEC:0001209191-21-048789:1
- 7,257 shares0Ordinary SharesSEC:0001209191-21-048789:0
- 12,350 shares@ US$92.643.6% of flowOrdinary SharesSEC:0001209191-21-046194:1
- 14,626 shares@ US$93.124.2% of flowOrdinary SharesSEC:0001209191-21-046194:2
- 8,100 shares@ US$91.3591.6% of flowOrdinary SharesSEC:0001209191-21-046194:0
- 51,253 shares@ US$88.7014.1% of flowOrdinary SharesSEC:0001209191-21-026474:0
- 8,195 shares@ US$89.602.3% of flowOrdinary SharesSEC:0001209191-21-026474:1
- 6,165 shares@ US$90.301.7% of flowOrdinary SharesSEC:0001209191-21-026474:2
- 871 shares@ US$87.170.2% of flowOrdinary SharesSEC:0001209191-21-012410:1
- 1,965 shares0Ordinary SharesSEC:0001209191-21-012410:0
- 5,819 shares0Ordinary SharesSEC:0001209191-21-004996:0
- 2,578 shares@ US$77.430.6% of flowOrdinary SharesSEC:0001209191-21-004996:1
- 52,858 shares@ US$36.105.7% of flowOrdinary SharesSEC:0001209191-21-002413:2
25 of 73 declarations
